Abstract Details
|
Andrew B. Lassman, MD, FÂ鶹´«Ã½Ó³»
(Columbia University Irving Medical Center)
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Ryan T. Merrell, MD (NorthShore University HealthSystem) | No disclosure on file |
| Martin Van Den Bent | Martin Van Den Bent has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genenta. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fore Biotherapeutics. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Incyte. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimerix. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for European Journal of Cancer. Martin Van Den Bent has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuro-Oncology. |
| Priya U. Kumthekar, MD | Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Enclear. Dr. Kumthekar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orbus Therapeutics. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioclinica. Dr. Kumthekar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Kumthekar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Kumthekar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. Dr. Kumthekar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Exelixis. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Telix . Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Plus Therapeutics. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Belay Diagnostics. Dr. Kumthekar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for FYR Diagnostics. Dr. Kumthekar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BPGBio. Dr. Kumthekar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daikonos. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Kumthekar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Servier. |
| Andrew Scott | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| David Reardon (Center for Neuro-Oncology) | No disclosure on file |